|
|
|
|
|
|
|
|
|
|
Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer -- Berek et al. 27 (3): 418 -- Journal of Clinical Oncology
Thursday, January 15, 2009
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.